Sun Pharmaceutical Industries completes acquisition of InSite Vision Incorporated

InSite Vision Incorporated becomes indirect wholly owned subsidiary of Sun Pharma

Sun Pharmaceutical Industries announced the completion of its acquisition of InSite Vision Incorporated. The acquisition was completed by means of a short form merger under Delaware law. Post the short form merger, InSite has become an indirect wholly owned subsidiary of Sun Pharma.

Powered by Capital Market - Live News